UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Marijuana, the Endocannabinoid System and the Female Reproductive System

The Yale journal of biology & medicine, 2016-06, Vol.89 (2), p.175-191

Brents, Lisa K

2016

Volltextzugriff (PDF)

Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity

PloS one, 2011-07, Vol.6 (7), p.e21917

2011

Volltextzugriff (PDF)

Response to article - alternative interpretation of "there is reduced immunohistochemical staining of placental aromatase in severe neonatal opioid withdrawal syndrome"

The journal of maternal-fetal & neonatal medicine, 2023-12, Vol.36 (1), p.2183469-2183469

2023

Volltextzugriff (PDF)

The K2/Spice Phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products

Drug metabolism reviews, 2014-02, Vol.46 (1), p.72-85

2014

Volltextzugriff (PDF)

Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software

Neurotoxicology and teratology, 2021-03, Vol.84, p.106959-106959, Article 106959

2021

Volltextzugriff (PDF)

Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom

The International journal of drug policy, 2022-10, Vol.108, p.103817-103817, Article 103817

2022

Volltextzugriff (PDF)

Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs

Anti-cancer agents in medicinal chemistry, 2012-12, Vol.12 (10), p.1211-1220

2012

Volltextzugriff (PDF)

Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity

Biochemical pharmacology, 2012-04, Vol.83 (7), p.952-961

2012

Volltextzugriff (PDF)

Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome

Drug and alcohol dependence, 2023-08, Vol.249, p.110832-110832, Article 110832

2023

Volltextzugriff (PDF)

Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands

Drug metabolism and disposition, 2012-11, Vol.40 (11), p.2174-2184

2012

Volltextzugriff (PDF)

Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors

Toxicology and applied pharmacology, 2013-06, Vol.269 (2), p.100-108

2013

Volltextzugriff (PDF)

Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats

Frontiers in pharmacology, 2023-05, Vol.14, p.1123261-1123261

2023

Volltextzugriff (PDF)

AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies

Neuropharmacology, 2012-10, Vol.63 (5), p.905-915

2012

Volltextzugriff (PDF)

Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer

Molecular cancer therapeutics, 2012-07, Vol.11 (7), p.1421-1431

2012

Volltextzugriff (PDF)

384 Motives for kratom self-medication: contents of public comments solicited by the FDA

Journal of clinical and translational science, 2022-04, Vol.6 (s1), p.72-73

2022

Volltextzugriff (PDF)

Personality variables modify the relationship between childhood maltreatment history and poor functional outcomes

Psychiatry research, 2018-10, Vol.268, p.229-237

2018

Volltextzugriff (PDF)

Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy

The Journal of pharmacology and experimental therapeutics, 2013-09, Vol.346 (3), p.350-361

2013

Volltextzugriff (PDF)

In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome

The Journal of pharmacology and experimental therapeutics, 2019-07, Vol.370 (1), p.9-17

2019

Volltextzugriff (PDF)

A Major Glucuronidated Metabolite of JWH-018 Is a Neutral Antagonist at CB1 Receptors

Chemical research in toxicology, 2012-04, Vol.25 (4), p.825-827

2012

Volltextzugriff (PDF)

481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome

Journal of clinical and translational science, 2023-04, Vol.7 (s1), p.139-140

2023

Volltextzugriff (PDF)

The role of childhood maltreatment in the altered trait and global expression of personality in cocaine addiction

Journal of psychiatric research, 2015-05, Vol.64, p.23-31

2015

Volltextzugriff (PDF)

Perceived social support and socioeconomic status predict maternal delay discounting behavior and neural function in healthy postpartum women

Drug and alcohol dependence, 2017-02, Vol.171, p.e26-e26

2017

Volltextzugriff (PDF)

Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors

Bioorganic & medicinal chemistry letters, 2013-04, Vol.23 (7), p.2019-2021

2013

Volltextzugriff (PDF)

Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors

Xenobiotica, 2012-02, Vol.42 (2), p.139-156

2012

Volltextzugriff (PDF)

1 – 25 von 201

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Englisch
(201)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Marijuana, the Endocannabinoid System and the Female Reproductive System

Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity

Response to article - alternative interpretation of "there is reduced immunohistochemical staining of placental aromatase in severe neonatal opioid withdrawal syndrome"

The K2/Spice Phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products

Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software

Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom

Unifying mechanisms of action of the anticancer activities of triterpenoids and synthetic analogs

Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception

Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity

Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome

Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands

Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors

Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats

AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies

Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer

384 Motives for kratom self-medication: contents of public comments solicited by the FDA

Personality variables modify the relationship between childhood maltreatment history and poor functional outcomes

Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy

In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome

A Major Glucuronidated Metabolite of JWH-018 Is a Neutral Antagonist at CB1 Receptors

481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome

The role of childhood maltreatment in the altered trait and global expression of personality in cocaine addiction

Perceived social support and socioeconomic status predict maternal delay discounting behavior and neural function in healthy postpartum women

Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors

Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors

Suchergebnisse filtern